Abstract
Radiation cystitis is a potential complication following the therapeutic irradiation of pelvic cancers. Its clinical management remains unclear, and few preclinical data are available on its underlying pathophysiology. The therapeutic strategy is difficult to establish because few prospective and randomized trials are available. In this review, we report on the clinical presentation and pathophysiology of radiation cystitis. Then we discuss potential therapeutic approaches, with a focus on the immunopathological processes underlying the onset of radiation cystitis, including the fibrotic process. Potential therapeutic avenues for therapeutic modulation will be highlighted, with a focus on the interaction between mesenchymal stromal cells and macrophages for the prevention and treatment of radiation cystitis.
Reference131 articles.
1. Medical prevention and treatment of radiation-induced urological and nephrological complications;Rehailia-Blanchard;Cancer Radiother. J. Soc. Fr. Radiother. Oncol.,2019
2. Incidence and Morbidity of Radiation-Induced Hemorrhagic Cystitis in Prostate Cancer
3. CTCAE versión 5.0. Evaluación de la gravedad de los eventos adversos dermatológicos de las terapias antineoplásicas
4. Management of radiation cystitis;Rigaud;Progres. En. Urol. J. Assoc. Fr. Urol. Soc. Fr. Urol.,2004
5. Management of radiation cystitis
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献